Novartis AG will look for acquisitions in the range of $2 billion to $4 billion each in 2013, Bloomberg reported citing Joe Jimenez, Chief Executive Officer of Novartis. Novartis doesn't plan to sell its vaccines, animal health, and consumer health businesses, Bloomberg reported.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99.06 CHF | +0.16% |
|
+0.77% | +16.72% |
07-15 | Brace for a flurry of speeches from Fed officials | ![]() |
07-15 | European companies cut jobs as economy sputters | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.72% | 225B | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.54% | 179B | |
+4.31% | 167B | |
+2.52% | 125B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Seeks Acquisitions